DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer (Q39648524)

13 September 2017

title

DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer (English)

1 reference

13 September 2017

1 reference

V Moncho-Amor

1

1 reference

13 September 2017

I Ibañez de Cáceres

2

1 reference

13 September 2017

E Bandres

3

1 reference

13 September 2017

B Martínez-Poveda

4

1 reference

13 September 2017

J L Orgaz

5

1 reference

13 September 2017

I Sánchez-Pérez

6

1 reference

13 September 2017

S Zazo

7

1 reference

13 September 2017

A Rovira

8

1 reference

13 September 2017

J Albanell

9

1 reference

13 September 2017

B Jiménez

10

1 reference

13 September 2017

F Rojo

11

1 reference

13 September 2017

C Belda-Iniesta

12

1 reference

13 September 2017

J García-Foncillas

13

1 reference

13 September 2017

R Perona

14

1 reference

13 September 2017

language of work or name

English

0 references

publication date

4 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

30

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

668-678

1 reference

Angiogenesis in life, disease and medicine

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Somatic mutations affect key pathways in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Targeting RAS and PI3K in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

ErbB receptors and signaling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Dual-specificity MAP kinase phosphatases (MKPs) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Mitogen-activated protein kinases in apoptosis regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Computer-assisted analysis of biopsy specimen microvessels predicts the outcome of esophageal cancers treated with chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.449

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.449

1 reference

Dimensions Publication ID

13 September 2017

1025087169

0 references

1 reference